-
-
-
-
-
-
-
Clear Street on Palisade Bio Inc. (PALI): stock reaction 'misaligned with fundamentals,' buying oppty
-
-
-
-
-
-
-
Clear Street Starts Palisade Bio Inc. (PALI) at Buy
-
-
-
-
-
-
-
JTC Team Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference Now Live
-
-
-
-
-
-
-
Palisade Bio Inc. (PALI) Presents Positive Preclinical Data of PALI-2108 for the Treatment of Ulcerative Colitis
-
-
-
-
-
-
-
Palisade Bio Inc. (PALI) Files for Share and Warrant Offering
-
-
-
-
-
-
-
Palisade Bio Inc. (PALI) Announces European Patent Office Issued a Decision to Grant Notice for Patent for Lead Product Candidate, PALI-2108
-
-
-
456,289 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

